ES3023054T3 - Methods for the treatment of ocular disease in human subjects - Google Patents

Methods for the treatment of ocular disease in human subjects Download PDF

Info

Publication number
ES3023054T3
ES3023054T3 ES20178612T ES20178612T ES3023054T3 ES 3023054 T3 ES3023054 T3 ES 3023054T3 ES 20178612 T ES20178612 T ES 20178612T ES 20178612 T ES20178612 T ES 20178612T ES 3023054 T3 ES3023054 T3 ES 3023054T3
Authority
ES
Spain
Prior art keywords
drug
microneedle
eye
scs
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES20178612T
Other languages
English (en)
Spanish (es)
Inventor
Vladimir Zarnitsyn
Samirkumar Patel
Daniel White
Glenn Noronha
Brian Burke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clearside Biomedical Inc
Original Assignee
Clearside Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clearside Biomedical Inc filed Critical Clearside Biomedical Inc
Application granted granted Critical
Publication of ES3023054T3 publication Critical patent/ES3023054T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0061—Methods for using microneedles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
ES20178612T 2012-11-08 2013-11-08 Methods for the treatment of ocular disease in human subjects Active ES3023054T3 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261724144P 2012-11-08 2012-11-08
US201261734872P 2012-12-07 2012-12-07
US201261745237P 2012-12-21 2012-12-21
US201361773124P 2013-03-05 2013-03-05
US201361785229P 2013-03-14 2013-03-14
US201361819388P 2013-05-03 2013-05-03
US201361873660P 2013-09-04 2013-09-04
US201361898926P 2013-11-01 2013-11-01

Publications (1)

Publication Number Publication Date
ES3023054T3 true ES3023054T3 (en) 2025-05-29

Family

ID=50685178

Family Applications (2)

Application Number Title Priority Date Filing Date
ES20178612T Active ES3023054T3 (en) 2012-11-08 2013-11-08 Methods for the treatment of ocular disease in human subjects
ES13853777T Active ES2813869T3 (es) 2012-11-08 2013-11-08 Métodos para el tratamiento de la enfermedad ocular en sujetos humanos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES13853777T Active ES2813869T3 (es) 2012-11-08 2013-11-08 Métodos para el tratamiento de la enfermedad ocular en sujetos humanos

Country Status (15)

Country Link
US (10) US20150258120A1 (enExample)
EP (3) EP3721872B1 (enExample)
JP (5) JP6487848B2 (enExample)
KR (3) KR20150083117A (enExample)
CN (2) CN104884049A (enExample)
AU (2) AU2013342275B2 (enExample)
BR (1) BR112015010566A2 (enExample)
CA (2) CA3240136A1 (enExample)
EA (1) EA034963B1 (enExample)
ES (2) ES3023054T3 (enExample)
IL (1) IL238432B (enExample)
MX (2) MX373894B (enExample)
PH (1) PH12015500986A1 (enExample)
SG (1) SG11201503637SA (enExample)
WO (1) WO2014074823A1 (enExample)

Families Citing this family (198)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2393768T3 (es) 2005-05-26 2012-12-27 Neuron Systems, Inc Derivado de quinolina para el tratamiento de enfermedades retinianas
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
EA201692543A1 (ru) 2005-11-23 2017-08-31 Акселерон Фарма Инк. Антагонисты активина-actriia и их применение для стимулирования роста кости
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
AU2007237096C1 (en) 2006-04-07 2012-12-13 EyePoint Pharmaceuticals, Inc. Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
US7622593B2 (en) 2006-06-27 2009-11-24 The Procter & Gamble Company Human protein tyrosine phosphatase inhibitors and methods of use
US8895016B2 (en) 2006-12-18 2014-11-25 Acceleron Pharma, Inc. Antagonists of activin-actriia and uses for increasing red blood cell levels
MX354099B (es) 2007-02-01 2018-02-13 Acceleron Pharma Inc Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
TWI432449B (zh) 2007-02-02 2014-04-01 Acceleron Pharma Inc 衍生自ＡｃｔＲＩＩＢ的變體與其用途
KR20160129095A (ko) 2007-02-09 2016-11-08 악셀레론 파마 인코포레이티드 액티빈-ＡｃｔＲⅡＡ 길항제 및 암 환자에서 골 생장을 촉진시키기 위한 이의 용도
CA2699936A1 (en) 2007-09-18 2009-03-26 Acceleron Pharma Inc. Activin-actriia antagonists and uses for decreasing or inhibiting fsh secretion
PT2340031T (pt) 2008-08-14 2019-07-25 Acceleron Pharma Inc Armadilhas de gdf para uso no tratamento de anemia
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
EP2440577A4 (en) 2009-06-12 2013-01-23 Acceleron Pharma Inc SHORTEN ACTRIIB FC FUSION PROTEINS
CA2748765C (en) 2009-07-06 2014-07-22 Akebia Therapeutics Inc. Compounds, compositions, and methods for preventing metastasis of cancer cells
WO2011063018A1 (en) 2009-11-17 2011-05-26 Acceleron Pharma Inc. Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
WO2011072141A1 (en) 2009-12-11 2011-06-16 Neuron Systems, Inc. Compositions and methods for the treatment of macular degeneration
WO2011106702A2 (en) 2010-02-25 2011-09-01 The Johns Hopkins University Sustained delivery of therapeutic agents to an eye compartment
EP3578205A1 (en) 2010-08-06 2019-12-11 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
CN103429606A (zh) 2010-10-01 2013-12-04 现代治疗公司 设计核酸及其使用方法
CN106214321B (zh) 2010-10-15 2018-08-28 科尼尔赛德生物医学公司 用于进入眼睛的装置
US20120121576A1 (en) 2010-11-08 2012-05-17 Jasbir Seehra Actriia binding agents and uses thereof
CA2831613A1 (en) 2011-03-31 2012-10-04 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
KR20190099538A (ko) 2011-10-03 2019-08-27 모더나 세라퓨틱스, 인코포레이티드 변형된 뉴클레오사이드, 뉴클레오타이드, 및 핵산, 및 이들의 용도
EP3505182A1 (en) 2011-10-13 2019-07-03 Aerpio Therapeutics, Inc. Methods for treating vascular leak syndrome and cancer
EP4144378A1 (en) 2011-12-16 2023-03-08 ModernaTX, Inc. Modified nucleoside, nucleotide, and nucleic acid compositions
US9254311B2 (en) 2012-04-02 2016-02-09 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins
AU2013243954A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
MX366336B (es) 2012-11-02 2019-07-05 Celgene Corp Antagonistas de activina - actrii y usos para el tratar trastornos oseos y otros.
EP3721872B1 (en) * 2012-11-08 2025-01-22 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
DK2922554T3 (en) 2012-11-26 2022-05-23 Modernatx Inc Terminalt modificeret rna
MA38274A1 (fr) * 2013-01-18 2017-02-28 Advenchen Pharmaceuticals Llc Procédé pour l'élaboration d'un agent antitumoral, la 6-(7-((1-amino-cyclo-propyl)-méthoxy)-6- méthoxyquinolin-4-yloxy)-n-méthyl-1-naphthamide, et de sa forme cristalline
CN117045653A (zh) 2013-01-23 2023-11-14 奥尔德拉医疗公司 与毒性醛相关的疾病和治疗
CA3144684A1 (en) 2013-03-05 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US20150050277A1 (en) 2013-03-15 2015-02-19 Aerpio Therapeutics Inc. Compositions and methods for treating ocular diseases
EP2991706B1 (en) 2013-05-03 2021-06-23 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
AU2014270497A1 (en) * 2013-05-24 2015-11-12 Bayer Healthcare Llc Treatment of polypoidal choroidal vasculopathy
WO2014197317A1 (en) 2013-06-03 2014-12-11 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
WO2014203182A1 (en) * 2013-06-20 2014-12-24 Novartis Ag Use of a vegf antagonist in treating choroidal neovascularisation
USD756524S1 (en) * 2013-08-05 2016-05-17 Xialing Zhang Protective cover for a subdermal needle electrode cable assembly
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
BR112016007255A2 (pt) 2013-10-03 2017-09-12 Moderna Therapeutics Inc polinucleotídeos que codificam receptor de lipoproteína de baixa densidade
EP3081169B1 (en) 2013-12-12 2023-06-28 Samsung Medison Co., Ltd. Method and apparatus for displaying ultrasonic image
US10010447B2 (en) 2013-12-18 2018-07-03 Novartis Ag Systems and methods for subretinal delivery of therapeutic agents
JP2017503028A (ja) * 2014-01-16 2017-01-26 オントジェネシス・エル・エル・シー 眼内血管新生及び／または漏出を治療するための組成物及び方法
EP4555981A3 (en) 2014-02-12 2025-08-06 Genentech, Inc. Method and apparatus for suprachoroidal administration of therapeutic agent
CN106456614A (zh) 2014-03-14 2017-02-22 爱尔皮奥治疗有限公司 HPTP‑β抑制剂
EP3145532A4 (en) * 2014-05-02 2018-02-21 Mayo Foundation for Medical Education and Research Individualized treatment of eye disease
US9925088B2 (en) 2014-06-06 2018-03-27 Janssen Biotech, Inc. Sub-retinal tangential needle catheter guide and introducer
US9949874B2 (en) 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
BR112016029226A2 (pt) 2014-06-13 2017-10-17 Acceleron Pharma Inc métodos e composições para o tratamento de úlceras
CA2952822A1 (en) * 2014-06-17 2015-12-23 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorders
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
EP3174540B9 (en) 2014-07-30 2021-05-05 Massachusetts Eye & Ear Infirmary Methotrexate for proliferative vitreoretinopathy
US10219936B2 (en) 2014-09-11 2019-03-05 Orbit Biomedical Limited Therapeutic agent delivery device with advanceable cannula and needle
US10258502B2 (en) 2014-09-18 2019-04-16 Orbit Biomedical Limited Therapeutic agent delivery device
AU2015345320A1 (en) 2014-11-10 2017-04-06 F. Hoffmann-La Roche Ag Anti-IL-1beta antibodies and methods of use
SG11201703426PA (en) * 2014-11-10 2017-05-30 Hoffmann La Roche Anti-pdgf-b antibodies and methods of use
RU2017120360A (ru) 2014-11-10 2018-12-13 Ф.Хоффманн-Ля Рош Аг Биспецифические антитела и способы их применения в офтальмологии
JP2017534644A (ja) 2014-11-10 2017-11-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 抗ａｎｇ２抗体及び使用方法
WO2016093299A1 (ja) * 2014-12-10 2016-06-16 千寿製薬株式会社 水性液剤
TWI597051B (zh) * 2015-04-16 2017-09-01 林伯剛 高半胱胺酸用於偵測及診斷人類眼部之息肉狀脈絡膜血管病變的用途及方法
TWI773641B (zh) * 2015-05-08 2022-08-11 日商活效製藥股份有限公司 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑
AU2016276170B2 (en) 2015-06-06 2021-08-05 Cloudbreak Therapeutics, Llc Compositions and methods for treating pterygium
EP3103491A1 (en) * 2015-06-10 2016-12-14 Sanofi-Aventis Deutschland GmbH A device for attachment to a drug delivery device
AU2016278040B2 (en) 2015-06-16 2019-07-04 Nanophagix LLC Drug delivery and imaging chemical conjugate, formulations and methods of use thereof
TWI700085B (zh) * 2015-06-22 2020-08-01 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物的用途
KR101778004B1 (ko) * 2015-06-22 2017-09-15 (주) 에빅스젠 이마티닙을 유효성분으로 포함하는 안구 건조 질환 예방 및 치료용 약학 조성물
US20190004048A1 (en) * 2015-06-26 2019-01-03 Amgen Inc. Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 Inhibitor
JP6914931B2 (ja) * 2015-07-23 2021-08-04 アエリエ ファーマシューティカルズ インコーポレイテッド 眼の症状の治療のための医薬組成物、硝子体内インプラント及び医薬品の製造におけるそれらの使用
US20170029499A1 (en) * 2015-07-31 2017-02-02 Astrazeneca Pharmaceuticals Lp Methods for treating hepcidin-mediated disorders
JP6947406B2 (ja) 2015-08-21 2021-10-13 アルデイラ セラピューティクス， インコーポレイテッド 重水素化化合物およびその使用
MX387804B (es) 2015-09-23 2025-03-19 Aerpio Therapeutics Inc Metodos para tratar presion intraocular con activadores de tie-2
TW201730211A (zh) * 2015-10-30 2017-09-01 建南德克公司 抗因子d抗體及結合物
CN108295072A (zh) * 2015-12-09 2018-07-20 瑞阳(苏州)生物科技有限公司 尼达尼布防治眼部疾病的用途
CN119857095A (zh) * 2015-12-17 2025-04-22 林科杰诺米克斯股份有限公司 脉络膜新生血管抑制剂或玻璃膜疣抑制剂及其评价或筛选方法
CN105496957A (zh) * 2015-12-22 2016-04-20 中山大学中山眼科中心 一种吡非尼酮缓释滴眼液
CA3010056A1 (en) 2015-12-30 2017-07-06 Kodiak Sciences Inc. Antibodies and conjugates thereof
CA3010862A1 (en) * 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
WO2017120600A1 (en) * 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Compositions and methods of treating wet age-related macular degeneration
JP7081818B2 (ja) 2016-02-04 2022-06-07 エーディーエス・セラピューティクス・エルエルシー 疾患治療のための抗体－薬剤相乗作用技術
CN116531400A (zh) 2016-02-28 2023-08-04 奥尔德拉医疗公司 用环糊精治疗过敏性眼部病状
US10478553B2 (en) 2016-03-09 2019-11-19 Orbit Biomedical Limited Apparatus for subretinal administration of therapeutic agent via a curved needle
RU2756109C2 (ru) 2016-03-10 2021-09-28 Виела Байо, Инк. Связывающие ilt7 молекулы и способы их применения
US20190099365A1 (en) * 2016-03-22 2019-04-04 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular biologic delivery
KR102574810B1 (ko) 2016-04-15 2023-09-08 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 습성 연령 관련 황반 변성의 치료를 위한 조성물
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
WO2017196881A1 (en) * 2016-05-09 2017-11-16 Aldeyra Therapeutics, Inc. Combination treatment of ocular inflammatory disorders and diseases
CN119656170A (zh) * 2016-06-02 2025-03-21 拨康视云生物医药科技(广州)有限公司 使用尼达尼布来治疗具有异常新生血管形成的眼病的组合物和方法
US10806629B2 (en) 2016-06-17 2020-10-20 Gyroscope Therapeutics Limited Injection device for subretinal delivery of therapeutic agent
US11000410B2 (en) 2016-06-17 2021-05-11 Gyroscope Therapeutics Limited Guide apparatus for tangential entry into suprachoroidal space
US10646374B2 (en) 2016-06-17 2020-05-12 Orbit Biomedical Limited Apparatus and method to form entry bleb for subretinal delivery of therapeutic agent
WO2018017714A1 (en) 2016-07-20 2018-01-25 Aerpio Therapeutics, Inc. HUMANIZED MONOCLONAL ANTIBODIES THAT TARGET VE-PTP (HPTP-ß)
US11278546B2 (en) * 2016-07-22 2022-03-22 Aiviva Biopharma, Inc. Multikinase inhibitors and uses in ocular fibrosis
CN110177527B (zh) 2016-08-12 2022-02-01 科尼尔赛德生物医学公司 用于调节药剂递送用针的插入深度的装置和方法
EP3515444A4 (en) * 2016-09-26 2020-06-03 Reyoung (Suzhou) Biology Science & Technology Co., Ltd COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION
KR20190134591A (ko) * 2016-12-15 2019-12-04 프로젠 피지500 시리즈 피티와이 리미티드 조성물 및 그의 용도
EP3554582A4 (en) 2016-12-16 2020-06-24 The Brigham and Women's Hospital, Inc. System and method for resistance-dependent, self-regulated medical penetration
US11273072B2 (en) 2017-01-13 2022-03-15 Gyroscope Therapeutics Limited Suprachoroidal injection device
TW202444416A (zh) 2017-02-01 2024-11-16 耶魯大學 心臟衰竭及心腎症候群之精準治療
WO2018162271A1 (en) * 2017-03-05 2018-09-13 Rita Dobmeyer Nanoparticles for the treatment of macular degeneration
US11076984B2 (en) 2017-03-13 2021-08-03 Gyroscope Therapeutics Limited Method of performing subretinal drainage and agent delivery
AU2018234919A1 (en) 2017-03-16 2019-09-19 Aldeyra Therapeutics, Inc. Polymorphic compounds and uses thereof
RU2643955C1 (ru) * 2017-04-19 2018-02-06 Галина Мэлсовна Чернакова Способ отбора и подготовки пробы клеток конъюнктивы для проведения бактериологического, вирусологического и иммунологического исследований
WO2018204515A1 (en) * 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
EP3622088A4 (en) * 2017-05-08 2021-04-14 Hadasit Medical Research Services&Development Ltd. BIOMARKERS FOR ANTI-TNF THERAPY FOR NETWORK DISEASES
CN111278401B (zh) * 2017-05-30 2023-08-15 艾克思摩尔有限公司 递送抗生素大环内酯治疗干眼综合征的组合物和方法
EP3638215A4 (en) 2017-06-15 2021-03-24 Modernatx, Inc. RNA FORMULATIONS
AU2018302022A1 (en) * 2017-07-17 2020-02-27 Macregen, Inc. Topical delivery of therapeutic agents comprising cell-penetrating peptides for use for the treatment of age-related macular degeneration and other eye diseases
CN111315359A (zh) 2017-08-31 2020-06-19 摩登纳特斯有限公司 制备脂质纳米颗粒的方法
CN111343970A (zh) 2017-09-13 2020-06-26 北卡罗莱纳州立大学 微针贴片局部诱导脂肪组织褐变治疗肥胖症
CN111712228B (zh) * 2017-09-15 2024-05-07 奥叙拉尔有限公司 眼科药物组合物
WO2019070727A2 (en) 2017-10-02 2019-04-11 The Johns Hopkins University NON-VIRAL GENE TRANSFER TO THE SUPRACHOROIDIAN SPACE
JP7311162B2 (ja) 2017-10-10 2023-07-19 アルデイラ セラピューティクス， インコーポレイテッド 炎症性障害の処置
CN107815453B (zh) * 2017-10-23 2020-08-07 中山大学中山眼科中心 一种核酸适配子及其用途
US20200316225A1 (en) * 2017-11-29 2020-10-08 Copernicus Therapeutics, Inc. Gene Therapy For Ocular Improvement
CN111512160B (zh) * 2017-12-21 2024-04-09 豪夫迈·罗氏有限公司 Htra1 rna拮抗剂的伴随诊断
WO2019136133A1 (en) * 2018-01-03 2019-07-11 The Trustees Of Columbia University In The City Of New York Microneedle for local delivery of therapeutic agent
KR20230047223A (ko) 2018-01-05 2023-04-06 노보 노르디스크 에이/에스 면역억제 없이 il-6 매개 염증을 치료하기 위한 방법
US20200345637A1 (en) * 2018-01-19 2020-11-05 Aiviva Biopharma, Inc. Suspension compositions of multi-target inhibitors
EA202091786A1 (ru) 2018-01-26 2020-10-20 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния Способы и композиции для лечения ангиогенных расстройств с применением агентов против фрэс
US11724941B2 (en) 2018-02-15 2023-08-15 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
CN112203679A (zh) 2018-03-02 2021-01-08 科达制药股份有限公司 Il-6抗体及其融合构建体和缀合物
US20190269702A1 (en) * 2018-03-05 2019-09-05 Clearside Biomedical, Inc. Compositions and methods for treating noninfectious uveitis
CN108452309B (zh) * 2018-03-05 2019-08-23 佳木斯大学附属第一医院 一种用于预防或治疗视神经炎的药物组合物及其制备方法
WO2019203310A1 (ja) * 2018-04-18 2019-10-24 株式会社ニコン 画像処理方法、プログラム、及び画像処理装置
WO2019217678A1 (en) * 2018-05-09 2019-11-14 North Carolina State University Applicator for corneal therapeutics
IL318714A (en) 2018-05-10 2025-03-01 Regeneron Pharma Formulations that include high concentrations of VEGF receptor fusion protein
WO2019226864A1 (en) * 2018-05-25 2019-11-28 Scott Whitcup A composition for treating ocular hyperemia and a method for treating ocular hyperemia with the same
WO2020028667A1 (en) * 2018-08-01 2020-02-06 Nanoneuron Therapeutics, Inc. Neuroprotective compositions and use thereof
US20210290727A1 (en) * 2018-08-01 2021-09-23 University Of Maryland, Baltimore MODULATION OF mTORCI ACTIVITY AND AUTOPHAGY VIA CIB2-RHEB INTERACTION
CN112714762A (zh) 2018-08-06 2021-04-27 奥尔德拉医疗公司 多晶型化合物及其用途
CN112805023A (zh) * 2018-08-21 2021-05-14 加州理工学院 无渗漏或最小渗漏的脉络膜或视网膜血管再生
CN109187987B (zh) * 2018-08-23 2021-05-11 中国人民解放军第三0九医院 Ms4a3蛋白作为标志物在诊断活动性结核病中的应用
WO2020061457A1 (en) 2018-09-20 2020-03-26 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
CN113056353B (zh) 2018-09-25 2022-11-01 奥尔德拉医疗公司 用于治疗干眼病的调配物
CN109172128A (zh) * 2018-09-28 2019-01-11 宜邻医疗科技（上海）有限公司 一种用于细胞和基因药物注入治疗的精准注射系统
CN110840893A (zh) * 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
JP2022516099A (ja) * 2018-12-27 2022-02-24 サーフィス オフサルミクス，インコーポレイテッド 眼科用医薬組成物及び癌表面疾患の処置方法
CN109799216B (zh) * 2018-12-29 2021-11-12 佛山科学技术学院 一种基于吲哚箐绿纳米的荧光oct双模成像方法和装置
US20220133908A1 (en) 2019-02-08 2022-05-05 Curevac Ag Coding rna administered into the suprachoroidal space in the treatment of ophthalmic diseases
JP7706758B2 (ja) 2019-03-26 2025-07-14 アルデイラ セラピューティクス， インコーポレイテッド 眼科用製剤およびその使用
US20220160694A1 (en) * 2019-04-08 2022-05-26 Biocryst Pharmaceuticals, Inc. Plasma kallikrein inhibitors and methods of use thereof in ocular disorders
KR20220019667A (ko) 2019-04-16 2022-02-17 클리어사이드 바이오메디컬, 인코포레이드 주사 가능한 트리암시놀론 제형
JP7564824B2 (ja) 2019-04-29 2024-10-09 アイポイント ファーマシューティカルズ， インコーポレイテッド シュレム管を標的とするＴｉｅ－２活性化物質
CN109999032A (zh) * 2019-04-30 2019-07-12 南昌大学 雷帕霉素在制备降眼内压的局部滴眼给药药物中的应用
EP3962894A4 (en) 2019-05-02 2023-01-11 Aldeyra Therapeutics, Inc. POLYMORPHIC COMPOUNDS AND USES THEREOF
WO2020223717A1 (en) 2019-05-02 2020-11-05 Aldeyra Therapeutics, Inc. Process for preparation of aldehyde scavenger and intermediates
WO2020227341A1 (en) * 2019-05-06 2020-11-12 9 Meters Biopharma, Inc. Compositions and methods for treating sjogren's syndrome
PL3773558T3 (pl) * 2019-05-10 2022-10-03 Synact Pharma Aps Leczenie skojarzone choroby zapalnej stawów
EP3976106A4 (en) * 2019-05-31 2023-01-11 DOSE Medical Corporation BIOERODABLE POLYESTER-POLYMER IMPLANTS AND ASSOCIATED METHODS OF USE
US20220370460A1 (en) 2019-09-13 2022-11-24 Aldeyra Therapeutics, Inc. Ophthalmic formulations of methotrexate
CN114786731A (zh) 2019-10-10 2022-07-22 科达制药股份有限公司 治疗眼部病症的方法
KR20220104756A (ko) 2019-11-25 2022-07-26 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 안구내 신생혈관형성을 위한 장기지속형 vegf 억제제
EP4094765A1 (en) * 2019-12-19 2022-11-30 Active Biotech AB Compounds for treatment of eye diseases associated with excessive vascularisation
EP4087542A4 (en) * 2020-01-06 2023-12-20 Shilpa Medicare Limited FINGOLIMOD SUSTAINED-RELEASE INJECTABLE SUSPENSION
DK3861985T3 (da) 2020-02-06 2023-07-24 Ocular Therapeutix Inc Sammensætninger og fremgangsmåder til behandling af øjensygdomme
CN119745879A (zh) * 2020-02-19 2025-04-04 科尼尔赛德生物医学公司 包含阿西替尼的组合物和治疗眼部疾病的方法
EP3884929B1 (en) 2020-03-25 2023-06-14 Ocular Therapeutix, Inc. Ocular implant containing a tyrosine kinase inhibitor
CN115803009A (zh) 2020-05-08 2023-03-14 瑞泽恩制药公司 用于治疗眼病和癌症的vegf阱和微阱及方法
CA3175856A1 (en) 2020-05-13 2021-11-18 Todd Brady Pharmaceutical formulations and uses thereof
CN116370408B (zh) * 2020-06-17 2025-12-02 成都瑞沐生物医药科技有限公司 一种滴眼给药治疗黄斑水肿、视神经炎和非感染性眼内炎的眼用制剂
CN112168487B (zh) * 2020-10-30 2024-12-17 重庆南坪爱尔眼科医院有限公司 一种反向青光眼滤过泡疤痕探通器
JP2024507327A (ja) * 2021-01-22 2024-02-19 チョンドゥー ルイムー バイオファーマスーティカルズ カンパニー リミテッド 眼科用製剤の担体または補助材料ならびにその調製方法および使用
WO2022226347A1 (en) * 2021-04-23 2022-10-27 AmMax Bio, Inc. Treatment of ophthalmic diseases
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
US12440510B2 (en) 2021-05-10 2025-10-14 Surface Ophthalmics, Inc. Use of chondroitin sulfate for relieving ocular pain
US12310981B2 (en) 2021-05-10 2025-05-27 Surface Ophthalmics, Inc. Use of chondroitin sulfate for relieving ocular pain
WO2022236779A1 (en) 2021-05-13 2022-11-17 Beijing Sightnovo Medical Technology Co., Ltd Medical penetration and drainage for glaucoma treatment
WO2022236778A1 (en) 2021-05-13 2022-11-17 Beijing Sightnovo Medical Technology Co., Ltd Medical penetration device and system
US20240342155A1 (en) * 2021-07-21 2024-10-17 Slbst Pharma, Inc. Hydroxychloroquine formulations, dosage forms, and methods of use
WO2023039168A1 (en) * 2021-09-09 2023-03-16 The Board Of Trustees Of The Leland Stanford Junior University Use of verteporfin to modulate wound healing after an ocular surgical procedure or ocular injury
EP4147709A1 (en) * 2021-09-14 2023-03-15 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth A composition comprising il-36 and/or il-18 for use in treating ocular disorders
CN114134195B (zh) * 2021-11-03 2024-06-11 南方科技大学 预防前列腺癌的药剂的筛选方法、硝唑尼特在制药中的应用
CN114099515A (zh) * 2021-12-27 2022-03-01 中山大学中山眼科中心 氨甲蝶呤在制备治疗视网膜色素变性的药物方面的应用
USD1037439S1 (en) 2022-01-17 2024-07-30 EyePoint Pharamaceuticals, Inc. Ocular injector
US20230233455A1 (en) * 2022-01-24 2023-07-27 Celanese Eva Performance Polymers Llc Method for Prohibiting and/or Treating an Eye Condition
CN119546310A (zh) * 2022-05-10 2025-02-28 加利福尼亚大学董事会 超低剂量唑来膦酸治疗视网膜疾病
CN117100874B (zh) * 2022-05-16 2025-10-31 苏州维益生物科技有限公司 纳米颗粒、其制备和应用、及包括其的眼疾药物及其制备
WO2024044745A2 (en) * 2022-08-26 2024-02-29 Asclepix Therapeutics, Inc. Formulations for intraocular delivery of peptides derived from type iv collagen
CN117100845A (zh) * 2022-10-24 2023-11-24 景泽生物医药(合肥)股份有限公司 重组人奥克纤溶酶在制备治疗脉络膜血管疾病药物中的用途
EP4615449A1 (en) * 2022-11-07 2025-09-17 Weinberg, Assa Method to prevent and treat diabetic retinopathy by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers
EP4615377A1 (en) 2022-11-11 2025-09-17 Beijing Sightnovo Medical Technology Co., Ltd Drug-containing devices, suprachoroidal space implants, and adapters for injection
US11911385B1 (en) 2022-12-14 2024-02-27 Aldeyra Therapeutics, Inc. Methotrexate treatment methods
IL322360A (en) 2023-04-11 2025-09-01 Ocular Therapeutix Inc Intraocular implant containing axitinib iv polymorph
WO2024226533A1 (en) * 2023-04-24 2024-10-31 Clearside Biomedical, Inc. Methods for treating ocular disorders with integrin antagonist composition
CN117224314B (zh) * 2023-08-28 2024-04-26 叶绿体(北京)生物医药有限公司 一种可降解式自密封眼球给药微针及其制备方法与应用
CN119925562B (zh) * 2023-11-03 2025-11-28 中国科学院上海药物研究所 趋化因子受体2拮抗剂在制备治疗糖尿病并发焦虑症的应用
KR20250119466A (ko) * 2024-01-31 2025-08-07 (주)노보메디슨 캐스파제 저해제의 용도
WO2025169089A1 (en) 2024-02-05 2025-08-14 Sun Pharmaceutical Industries Limited Ophthalmic compositions of tyrosine kinase inhibitors and their uses
WO2025217214A2 (en) 2024-04-08 2025-10-16 Regenxbio Inc. Recombinant adeno-associated viruses and uses thereof
WO2025217230A1 (en) 2024-04-08 2025-10-16 Regenxbio Inc. Vectorized anti-complement antibodies and complement agents and administration thereof
CN119331126B (zh) * 2024-10-22 2025-10-24 江南大学 一种用于溃疡性结肠炎治疗的口服纳米给药系统

Family Cites Families (418)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2008700A (en) 1930-05-12 1935-07-23 Jr John Hays Hammond Reediting of talking films
US2187259A (en) 1936-07-11 1940-01-16 George E Barnhart Hypodermic needle
US2841145A (en) 1956-05-07 1958-07-01 John A Epps Syringe
US2939459A (en) 1957-01-11 1960-06-07 Jorge A Lazarte Tandem syringe
US3477432A (en) 1964-07-21 1969-11-11 Joseph Denman Shaw Combination mixing and injecting medical syringe
US3376999A (en) 1967-05-31 1968-04-09 Gen Dynamics Corp Packaging, mixing and dispensing apparatus
US3892311A (en) 1969-01-31 1975-07-01 Vincent R Sneider Disposable syringe kit
AT318132B (de) 1969-08-01 1974-09-25 Dentaire Ivoclar Ets Mischbehälter für die Aufnahme von miteinander reagierenden Substanzen für die Herstellung von gebrauchsfertigen pastenförmigen Dentalpräparaten
US3762540A (en) 1970-05-19 1973-10-02 Dentaire Ivoclar Ets Receptacle having at least three chambers
US3964482A (en) 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
US3838690A (en) 1971-07-14 1974-10-01 B Friedman Replaceable cartridge hypodermic syringe having sterile maintenance of needle
US3788320A (en) 1972-02-25 1974-01-29 Kendall & Co Spinal needle
US3962430A (en) 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
US4226328A (en) 1979-04-09 1980-10-07 Baxter Travenol Laboratories, Inc. Catheterization package
US4383530A (en) 1981-06-05 1983-05-17 John Bruno Hypodermic needle and method of making needles
US4377897A (en) 1981-08-04 1983-03-29 Ocular Associates Ophthalmic needle and method for manufacturing the same
US4432964A (en) 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4525346A (en) * 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
JPS5875563A (ja) 1981-10-30 1983-05-07 テルモ株式会社 留置カテ−テル用接続具
US4564016A (en) 1982-05-24 1986-01-14 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for introducing ionized drugs into the posterior segment of the eye and method
WO1985000097A1 (fr) 1983-06-28 1985-01-17 Sterimed Gesellschaft Für Medizinischen Bedarf Mbh Appareils medicaux avec dispositif d'aide d'introduction
US4501363A (en) 1983-10-25 1985-02-26 Isbey Jr Edward K Surgical kit
NZ212899A (en) 1984-07-31 1987-10-30 Phillips Pty Ltd N J Piston operated adjustable volume dose injector for animals
US4708147A (en) 1985-02-25 1987-11-24 Haaga John R Universal biopsy needle
US4826871A (en) 1985-03-13 1989-05-02 Gressel Philip D Topical ophthalmic compositions containing one or more retinoids
US4689040A (en) 1985-04-29 1987-08-25 Thompson Robert J Tip for a phacoemulsification needle
US4689042A (en) 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
US4826490A (en) 1985-07-29 1989-05-02 National Research Development Corporation Safety device for hypodermic needle or the like
US4601708A (en) 1985-09-09 1986-07-22 Pavel Jordan Automatic injection for syringe needle, and assembly
US4736850A (en) 1986-10-17 1988-04-12 W. L. Gore & Associates, Inc. Endothelial cell harvesting kit
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4795432A (en) 1987-02-19 1989-01-03 Karczmer Claude M Shield assembly for hypodermic injection devices
US4804371A (en) 1987-05-06 1989-02-14 Vaillancourt Vincent L Post-injection needle sheath
EP0301246B1 (de) 1987-07-10 1992-02-05 B. Braun Melsungen AG Kanüle
DE3802158A1 (de) 1987-08-11 1989-02-23 Hoechst Ag Vorrichtung zur applikation von implantaten
US5547467A (en) 1988-01-21 1996-08-20 Massachusettes Institute Of Technology Method for rapid temporal control of molecular transport across tissue
US5066276A (en) 1988-06-21 1991-11-19 Alcon Laboratories, Inc. Method and apparatus for injecting viscous fluid into the eye to lift pre-retinal and post-retinal membrane with linear pressure control
JP2918946B2 (ja) 1988-09-23 1999-07-12 ハンター，フランク 口腔衛生における改良
US5817075A (en) 1989-08-14 1998-10-06 Photogenesis, Inc. Method for preparation and transplantation of planar implants and surgical instrument therefor
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5024662A (en) 1990-03-13 1991-06-18 Menes Cesar M Resistance syringe for epidural anesthesia
US5015240A (en) 1990-05-01 1991-05-14 Ian Campbell Cree Hypodermic needle shield
US5098389A (en) 1990-06-28 1992-03-24 Becton, Dickinson And Company Hypodermic needle assembly
ES2023597A6 (es) 1990-11-05 1992-01-16 Rodiera Olive Jose Javier Aguja para uso medico, en especial para funcion lumbar y anestesia regional.
US5273530A (en) 1990-11-14 1993-12-28 The University Of Rochester Intraretinal delivery and withdrawal instruments
EP0501034A1 (en) 1991-01-30 1992-09-02 CeramOptec GmbH Illuminated leading probe device
US5206267A (en) * 1991-05-09 1993-04-27 Morton Shulman Pain controlling composition and method of preparation
US5181909A (en) 1991-05-15 1993-01-26 Mcfarlane Richard H Ampule-container medical syringe and methods
DE4120173A1 (de) 1991-06-19 1992-12-24 Hoechst Ag Positiv arbeitendes strahlungsempfindliches gemisch und damit hergestelltes strahlungsempfindliches aufzeichnungsmaterial
US5312361A (en) 1991-09-13 1994-05-17 Zadini Filiberto P Automatic cannulation device
US5172807A (en) 1991-09-30 1992-12-22 Centrix, Inc. Cement mixing capsule
WO1993020784A1 (en) 1992-04-10 1993-10-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University A microneedle for injection of ocular blood vessels
US5767079A (en) 1992-07-08 1998-06-16 Celtrix Pharmaceuticals, Inc. Method of treating ophthalmic disorders using TGF -β
CA2138644A1 (en) 1992-07-08 1994-01-20 Bert M. Glaser Method of treating ophthalmic disorders using tgf-.beta.
US5295972A (en) 1992-08-04 1994-03-22 Metatech Corporation Hypodermic syringe with protective cap
US5279564A (en) 1992-09-11 1994-01-18 Edward Weck Incorporated Cannula retention device
US5300084A (en) 1992-11-23 1994-04-05 United States Surgical Corporation Pneumoperitoneum needle
EP0674528A4 (en) 1992-12-02 1996-06-26 Insite Vision Inc DRUG DELIVERY SYSTEM BASED ON CYCLODEXTRIN AND A POLYMER.
US5320609A (en) 1992-12-07 1994-06-14 Habley Medical Technology Corporation Automatic pharmaceutical dispensing syringe
US5681825A (en) 1993-03-15 1997-10-28 Lindqvist; Bengt Surgical method
US5399159A (en) 1993-03-30 1995-03-21 Origin Medsystems, Inc. Apparatus and method for hand-held insufflation
US5407070A (en) 1993-08-18 1995-04-18 Bascos; Christine M. One-time resealable package for needled medical devices
US5415629A (en) 1993-09-15 1995-05-16 Henley; Julian L. Programmable apparatus for the transdermal delivery of drugs and method
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5354286A (en) 1993-12-07 1994-10-11 Survival Technology, Inc. Injection device having polyparaxylylene coated container
US5397313A (en) 1994-01-27 1995-03-14 The Kendall Company Low friction syringe
US5658256A (en) 1994-08-22 1997-08-19 Shields; Jack W. Universal sharps shield
SE9402816D0 (sv) 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
AU3584895A (en) 1994-09-28 1996-04-19 Celtrix Pharmaceuticals, Inc. Method of treating macular degeneration using tgf-beta
US5856152A (en) 1994-10-28 1999-01-05 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV vector and methods of use therefor
US5856153A (en) 1994-11-17 1999-01-05 Cayla Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases
US5792099A (en) 1995-02-14 1998-08-11 Decamp; Dennis Syringe and cannula for insertion of viscoelastic material into an eye and method of using same
US5779668A (en) 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration
US5968022A (en) 1995-04-28 1999-10-19 Saito; Yoshikuni Medical hollow needle and method of production
USD383049S (en) 1995-06-30 1997-09-02 Fiskars Inc. Tool handle grip
US6280470B1 (en) 1995-10-20 2001-08-28 Gholam A. Peyman Intrastromal corneal modification
US5788679A (en) 1996-06-26 1998-08-04 Gravlee, Jr.; Joseph F. Phacoemulsification needle
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5911223A (en) 1996-08-09 1999-06-15 Massachusetts Institute Of Technology Introduction of modifying agents into skin by electroporation
IT237434Y1 (it) 1997-04-17 2000-09-13 Philco Italiana Lavatrice con carrello per il suo spostamento
PL199565B1 (pl) 1997-05-16 2008-10-31 Amgen Inc Preparat farmaceutyczny zawierający kompozycję o przedłużonym uwalnianiu oraz zastosowanie preparatu farmaceutycznego zawierającego kompozycję o przedłużonym uwalnianiu
AUPO940697A0 (en) 1997-09-23 1997-10-16 Kaal, Joseph Hermes Retractable syringe
WO1999034858A1 (en) 1998-01-12 1999-07-15 Georgia Tech Research Corporation Assessment and control of acoustic tissue effects
AU2895899A (en) 1998-03-04 1999-09-20 Medtronic, Inc. Medical device packaging system
US6309347B1 (en) 1998-03-17 2001-10-30 Fuji Photo Optical Co., Ltd. Air and water supply system for endoscopes
JP2951938B1 (ja) 1998-03-19 1999-09-20 日本ケミカルリサーチ株式会社 薬剤溶解機構を内蔵した注射器
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6540725B1 (en) 1998-06-04 2003-04-01 Biosense Webster, Inc. Injection catheter with controllably extendable injection needle
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6936053B1 (en) 1998-07-02 2005-08-30 Jeffrey N. Weiss Ocular implant needle
US6378526B1 (en) 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
US6309374B1 (en) 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
CA2346262A1 (en) 1998-09-17 2000-03-23 University Of Florida Methods for treatment of degenerative retinal diseases
FR2784034B1 (fr) 1998-10-01 2000-12-15 Marc Brunel Dispositif d'injection a usage unique destine a etre pre-rempli
US6219575B1 (en) 1998-10-23 2001-04-17 Babak Nemati Method and apparatus to enhance optical transparency of biological tissues
US20040141925A1 (en) * 1998-11-12 2004-07-22 Elan Pharma International Ltd. Novel triamcinolone compositions
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
US6773916B1 (en) 1999-01-05 2004-08-10 The Flinders University Of South Australia Agents and methods for treatment and diagnosis of ocular disorders
US6699210B2 (en) 1999-04-27 2004-03-02 The Arizona Board Of Regents Glaucoma shunt and a method of making and surgically implanting the same
US6159218A (en) 1999-05-19 2000-12-12 Aramant; Robert B. Retinal tissue implantation tool
US6319240B1 (en) 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
FR2794650B1 (fr) 1999-06-10 2001-09-14 Marc Brunel Dispositif d'injection a usage unique
FR2801795B1 (fr) 1999-12-07 2002-07-05 Plastef Investissements Dispositif de support de securite pour une seringue et ensemble d'un tel dispositif et d'une seringue
CA2393673A1 (en) 1999-12-10 2001-06-14 Iscience Corporation Treatment of ocular disease
US20010051798A1 (en) 1999-12-28 2001-12-13 Hochman Mark N. Method of performing an injection using a bi-directional rotational insertion technique
US6726676B2 (en) 2000-01-05 2004-04-27 Grieshaber & Co. Ag Schaffhausen Method of and device for improving the flow of aqueous humor within the eye
RU14351U1 (ru) 2000-02-15 2000-07-20 Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" Игла-направитель для пункции ретробульбарного пространства
JP4372310B2 (ja) 2000-04-10 2009-11-25 ニプロ株式会社 混注用アダプター
US6622864B1 (en) 2000-06-01 2003-09-23 Osteotech, Inc. Moisture resistant package for storing sterile items
JP4187922B2 (ja) 2000-09-14 2008-11-26 テルモ株式会社 液体注入針および液体注入装置
CA2426600A1 (en) 2000-10-31 2002-05-23 Smith & Nephew, Inc. Packaging and delivery system for bone graft particles
US20030060447A1 (en) 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US6915901B2 (en) 2000-12-11 2005-07-12 Marc Feinberg Packaging assembly for surgical use
EP1345646A2 (en) 2000-12-14 2003-09-24 Georgia Tech Research Corporation Microneedle devices and production thereof
US6387078B1 (en) 2000-12-21 2002-05-14 Gillespie, Iii Richard D. Automatic mixing and injecting apparatus
US20030171722A1 (en) 2001-01-04 2003-09-11 Michel Paques Microsurgical injection and/or distending instruments and surgical method and apparatus utilizing same
JP4194842B2 (ja) 2001-01-18 2008-12-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 低侵襲的緑内障外科用器具および方法
US6378849B1 (en) * 2001-04-13 2002-04-30 General Electric Company Methods and apparatus for mounting motors
US20090088721A1 (en) 2001-04-17 2009-04-02 Eyegate Pharma S.A.S. Enhanced retinal delivery of a nucleic acid through iontophoresis
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US20030073609A1 (en) 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US6749792B2 (en) 2001-07-09 2004-06-15 Lifescan, Inc. Micro-needles and methods of manufacture and use thereof
AU2002317573B2 (en) 2001-07-24 2007-07-26 Artes Medical, Inc. Elongated syringe
JP2003052819A (ja) 2001-08-10 2003-02-25 Seikagaku Kogyo Co Ltd 薬剤充填注射器包装物およびその滅菌または殺菌方法
US8361037B2 (en) 2001-09-19 2013-01-29 Valeritas, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
WO2003024508A2 (en) 2001-09-21 2003-03-27 Biovalve Technologies, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US7429258B2 (en) 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US7569035B1 (en) 2001-11-02 2009-08-04 Meridian Medical Technologies, Inc. Automatic injector with anti-coring needle
DE50210569D1 (de) 2001-11-22 2007-09-06 Eduard Anton Haefliger Vorrichtung zur durchführung ophtalmologischer eingriffe
US7204823B2 (en) 2001-12-19 2007-04-17 Medtronic Minimed, Inc. Medication delivery system and monitor
US6821286B1 (en) 2002-01-23 2004-11-23 Cardica, Inc. System for preparing a graft vessel for anastomosis
US20050033230A1 (en) 2002-02-15 2005-02-10 Alchas Paul G. Prefillable intradermal delivery device with hidden needle and passive shielding
PT1484054E (pt) 2002-02-22 2012-11-28 Santen Pharmaceutical Co Ltd Sistema de administração de fármaco para administração subconjuntival de partículas finas
ES2347544T3 (es) 2002-03-13 2010-11-02 Janssen Pharmaceutica Nv Inhibidores de histona-desacetilasas.
US20050148034A1 (en) 2002-04-12 2005-07-07 Hariri Robert J. Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
US7198606B2 (en) 2002-04-19 2007-04-03 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with analyte sensing
AU2003241481B2 (en) 2002-05-16 2008-09-04 Scott Laboratories, Inc. Drug container entry mechanisms and method
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
US7316676B2 (en) 2002-08-20 2008-01-08 Gholam A. Peyman Treatment of retinal detachment
DE10242984B4 (de) 2002-09-17 2010-09-23 Sanatis Gmbh Vorrichtung zum Herstellen von Gemischen aus zwei Komponenten
PL223153B1 (pl) 2002-09-18 2016-10-31 Allergan Inc Urządzenie do wszczepiania implantu okulistycznego
JP2006507368A (ja) 2002-09-29 2006-03-02 サーモディックス，インコーポレイティド ステロイド含有治療剤の網膜下投与方法；脈絡膜及び網膜に薬力学作用を局在化するための方法；並びに網膜疾患の治療及び／又は予防のための関連する方法
WO2004033021A1 (en) 2002-10-07 2004-04-22 Biovalve Technologies, Inc. Microneedle array patch
US6883222B2 (en) 2002-10-16 2005-04-26 Bioject Inc. Drug cartridge assembly and method of manufacture
KR20050085367A (ko) 2002-12-04 2005-08-29 산텐 세이야꾸 가부시키가이샤 결막하 데포에 의한 약물 송달 시스템
JP2004196787A (ja) 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
EP1589901A4 (en) 2002-12-20 2006-08-09 Generipharm Inc INTRACUTANEOUS INJECTION
CA2513705A1 (en) 2003-01-21 2004-08-05 Carmel Pharma Ab A needle for penetrating a membrane
GB0301934D0 (en) 2003-01-28 2003-02-26 Sundar Satish Delivery apparatus and location method
JP4444122B2 (ja) 2003-02-24 2010-03-31 ベクトン・ディキンソン・フランス・エス．エー．エス． 一団の注射器本体物を保持するプレート
US20040186084A1 (en) 2003-03-21 2004-09-23 Akorn, Inc. Triamcinolone formulations and methods for their preparation and use
US20040199130A1 (en) 2003-04-03 2004-10-07 Chornenky Victor I. Apparatus and method for treatment of macular degeneration
US7533514B2 (en) 2003-04-25 2009-05-19 Boston Scientific Scimed, Inc. Method and apparatus for automated handling of medical devices during manufacture
US7435237B2 (en) 2003-06-02 2008-10-14 Boston Scientific Scimed, Inc. Mixing syringes with breakable septums
US8403941B2 (en) 2003-06-02 2013-03-26 Abbott Medical Optics Inc. Intraocular lens and cartridge packaging with lens-loading function
WO2005000382A2 (en) 2003-06-04 2005-01-06 Georgia Tech Research Corporation Drilling microneedle device
DE10327119A1 (de) 2003-06-13 2004-12-30 Aventis Pharma Deutschland Gmbh Kappe für Injektionsvorrichtungen
US7914803B2 (en) 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
WO2004110391A2 (en) 2003-06-16 2004-12-23 Solx, Inc. Shunt for the treatment of glaucoma
PL1638468T3 (pl) 2003-06-30 2008-01-31 Alza Corp Sposób powlekania mikrowystępów do przekłuwania skóry
USD499153S1 (en) 2003-07-08 2004-11-30 Test Rite International Company, Ltd Handle for jump rope
US20050009910A1 (en) 2003-07-10 2005-01-13 Allergan, Inc. Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
EP1663144A1 (en) * 2003-09-23 2006-06-07 Alcon, Inc. Triamcinolone acetonide and anecortave acetate formulations for injection
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20050101882A1 (en) 2003-11-12 2005-05-12 Leira Enrique C. Safety pressure device for body fluid extraction
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
JP2007520276A (ja) 2004-01-12 2007-07-26 アイサイエンス・インターベンショナル・コーポレーション 粘性材料のための注入器
WO2005072701A1 (en) 2004-01-20 2005-08-11 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
KR101195052B1 (ko) 2004-01-23 2012-10-29 아이싸이언스 인터벤셔날 코포레이션 복합체 안과 마이크로캐뉼라
US7678077B2 (en) 2004-02-20 2010-03-16 Boston Scientific Scimed, Inc. Variable depth injection device and method
US7361168B2 (en) * 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US20080058704A1 (en) 2004-04-29 2008-03-06 Michael Hee Apparatus and Method for Ocular Treatment
KR20070036044A (ko) 2004-04-29 2007-04-02 아이싸이언스 인터벤셔날 코포레이션 안과 치료를 위한 장치와 방법
US20100173866A1 (en) 2004-04-29 2010-07-08 Iscience Interventional Corporation Apparatus and method for ocular treatment
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
CA2591267C (fr) 2004-04-30 2012-04-10 Eyegate Pharma S.A. Dispositif de iontophorese oculaire diminuant les irritations
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20050244462A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Devices and methods for treating a mammalian eye
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8690865B2 (en) 2004-05-28 2014-04-08 Georgia Tech Research Corporation Methods and devices for thermal treatment
US8323227B2 (en) 2004-07-02 2012-12-04 C. R. Bard, Inc. Tip configurations for a multi-lumen catheter
US20060009498A1 (en) 2004-07-12 2006-01-12 Allergan, Inc. Ophthalmic compositions and methods for treating ophthalmic conditions
US7615041B2 (en) 2004-07-29 2009-11-10 Boston Scientific Scimed, Inc. Vial adaptor
US7503920B2 (en) 2004-08-11 2009-03-17 Tzony Siegal Spinal surgery system and method
US7722669B2 (en) 2004-08-13 2010-05-25 Richard Foulkes Method and insert for modifying eye color
US8114110B2 (en) 2004-09-22 2012-02-14 St. Jude Medical, Atrial Fibrillation Division, Inc. Transseptal puncture needle and needle assemblies
US7947267B2 (en) 2004-10-08 2011-05-24 Potentia Pharmaceuticals, Inc. Viral complement control proteins for eye disorders
US7627938B2 (en) 2004-10-15 2009-12-08 Board Of Regents, The Univeristy Of Texas System Tapered hollow metallic microneedle array assembly and method of making and using the same
US7604647B2 (en) 2004-10-22 2009-10-20 Medical Instrument Development Laboratories, Inc. Ophthalmic cannula insertion tool and method
US7097776B2 (en) 2004-10-22 2006-08-29 Hewlett-Packard Development Company, L.P. Method of fabricating microneedles
US20060089590A1 (en) 2004-10-27 2006-04-27 John Higuchi Methods and devices for sustained in-vivo release of an active agent
CA2588433A1 (en) 2004-11-17 2006-05-26 Michael R. Robinson Steroid formulation and methods of treatment using same
US8262715B2 (en) 2004-11-23 2012-09-11 Eye Delivery System, Llc Medical device and method for temperature control and treatment of the eye and surrounding tissues via magnetic drug therapy
DE602005026978D1 (de) 2004-11-23 2011-04-28 Timothy L Lee Medizinische vorrichtung zur temperaturregelung und behandlung des auges sowie des umgebenden gewebes
US20060173418A1 (en) 2004-12-13 2006-08-03 Arrow International, Inc. Loss of resistance syringe
US20060169664A1 (en) 2004-12-28 2006-08-03 Holopack International Corp. Vial for filling a syringe
US7803142B2 (en) 2005-02-02 2010-09-28 Summit Access Llc Microtaper needle and method of use
TW200640443A (en) 2005-02-23 2006-12-01 Alcon Inc Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
US20060233858A1 (en) 2005-03-08 2006-10-19 Allergan, Inc. Systems and methods providing targeted intraocular drug delivery
EP1856259A1 (en) 2005-03-11 2007-11-21 Alcon Inc. Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
CA2601864A1 (en) 2005-04-08 2006-10-19 Surmodics, Inc. Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
US7722581B2 (en) 2005-04-11 2010-05-25 Gholam A. Peyman Crystalline lens drug delivery
US7645264B2 (en) 2005-04-11 2010-01-12 Becton, Dickinson And Company Injection device with secondary reservoir
KR100976281B1 (ko) 2005-04-26 2010-08-16 바이오레이즈 테크놀로지, 인크. 안구 치료 장치
US20060259008A1 (en) 2005-04-27 2006-11-16 Allergan, Inc. Apparatus and methods useful for intravitreal injection of drugs
CN100463668C (zh) 2005-05-09 2009-02-25 凌沛学 可逆性热凝胶化水性药物组合物
US20080269666A1 (en) 2005-05-25 2008-10-30 Georgia Tech Research Corporation Microneedles and Methods for Microinfusion
WO2006138719A2 (en) 2005-06-17 2006-12-28 Georgia Tech Research Corporation Coated microstructures and method of manufacture thereof
CN100430069C (zh) 2005-07-28 2008-11-05 凌沛学 一种中药及其复方的可逆性热凝胶化水性药物组合物
US20070082841A1 (en) 2005-09-27 2007-04-12 Aciont, Inc. Ocular administration of immunosuppressive agents
US20090082321A1 (en) 2007-09-21 2009-03-26 Allergan, Inc. Steroid containing drug delivery systems
US20070093877A1 (en) 2005-10-26 2007-04-26 Beecham Michael C System for maintaining normal health of retinal cells and promoting regeneration of retinal cells
CA2627392A1 (en) 2005-11-14 2007-05-24 Pactiv Corporation Container having internal reservoir
US20070123947A1 (en) 2005-11-30 2007-05-31 Wenger William K Medical device packaging system
CA2634077A1 (en) 2005-12-23 2007-06-28 Cathrx Ltd Irrigation catheter
EP3338743A1 (en) 2006-01-17 2018-06-27 Novartis Ag Drug delivery treatment device
US20070185495A1 (en) 2006-01-30 2007-08-09 Howmedica International S. De R. L. Plug-in syringe stand
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
ES2355937T3 (es) 2006-04-27 2011-04-01 Ecolab Inc. Montaje de distribución de productos sólidos.
WO2007131050A2 (en) 2006-05-02 2007-11-15 Georgia Tech Research Corporation Method for drug delivery to ocular tissue using microneedle
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
US20070270768A1 (en) 2006-05-17 2007-11-22 Bruno Dacquay Mechanical Linkage Mechanism For Ophthalmic Injection Device
US20070270745A1 (en) 2006-05-18 2007-11-22 Camran Nezhat Vacuum actuated tissue lifting device
USD598543S1 (en) 2006-06-13 2009-08-18 Angiomed Gmbh & Co. Medizintechnik Kg Handle for a medical delivery device
US8668676B2 (en) 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8974511B2 (en) 2010-11-15 2015-03-10 Aquesys, Inc. Methods for treating closed angle glaucoma
US8852137B2 (en) 2010-11-15 2014-10-07 Aquesys, Inc. Methods for implanting a soft gel shunt in the suprachoroidal space
US8663303B2 (en) 2010-11-15 2014-03-04 Aquesys, Inc. Methods for deploying an intraocular shunt from a deployment device and into an eye
WO2008011125A2 (en) 2006-07-20 2008-01-24 Neurosystec Corporation Devices, systems and methods for ophthalmic drug delivery
US20080097335A1 (en) 2006-08-04 2008-04-24 Allergan, Inc. Ocular implant delivery assemblies
US20080058717A1 (en) 2006-09-04 2008-03-06 Spector David M Oral cavity liquid delivery system including pre-angled needle guidance assembly and method for using the same
US7998108B2 (en) 2006-09-12 2011-08-16 Psivida Us, Inc. Injector apparatus and method of use
US8944069B2 (en) 2006-09-12 2015-02-03 Vidacare Corporation Assemblies for coupling intraosseous (IO) devices to powered drivers
US20080097346A1 (en) 2006-09-19 2008-04-24 Alcon, Inc. Trocar cannula
US20080097390A1 (en) 2006-09-27 2008-04-24 Alcon Manufacturing, Ltd. Spring actuated delivery system
CA2668954C (en) 2006-11-10 2020-09-08 Glaukos Corporation Uveoscleral shunt and methods for implanting same
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
CA2670990A1 (en) 2006-12-01 2008-06-12 Allergan, Inc. Method for determining optimum intraocular locations for drug delivery systems
RU2344767C2 (ru) 2006-12-18 2009-01-27 Наталья Александровна Уракова Способ внутриартериальной инъекции по а.л. уракову
TWI457336B (zh) * 2006-12-28 2014-10-21 Kinex Pharmaceuticals Llc 調節激酶級聯之組成物及方法
JP5201743B2 (ja) 2007-01-09 2013-06-05 フォヴェア ファルマシューティカル 眼内注射装置
US20080177239A1 (en) 2007-01-18 2008-07-24 Yong Li Trocar cannula system
DE102007018696A1 (de) 2007-04-18 2008-10-23 Sanofi-Aventis Deutschland Gmbh Injektionsvorrichtung zur Abgabe eines Medikaments
USD590690S1 (en) 2007-05-24 2009-04-21 Domino S.P.A. Handlebar hand grip
US20090030381A1 (en) 2007-07-23 2009-01-29 Lind Casey J Arced Hypodermic Needle
AU2008287317A1 (en) 2007-08-16 2009-02-19 East Carolina University Smart injection syringe systems providing real-time user feedback of correct needle position
AU2008300018A1 (en) 2007-09-07 2009-03-19 Qlt Inc. Insertion and extraction tools for lacrimal implants
CA2639322C (en) 2007-09-07 2016-11-08 Becton, Dickinson And Company Pen needle hub having increased contact area
US20090076463A1 (en) 2007-09-17 2009-03-19 Jurg Attinger Trocar Cannula
US20090081277A1 (en) 2007-09-21 2009-03-26 Allergan, Inc. Pharmaceutical formulations and methods for treating ocular conditions
US8083759B2 (en) 2007-11-02 2011-12-27 Refocus Ocular, Inc. Apparatuses and methods for forming incisions in ocular tissue
US8631935B2 (en) 2009-06-03 2014-01-21 Medline Industries, Inc. Catheter tray, packaging system, and associated methods
US8448786B2 (en) 2009-06-30 2013-05-28 Medline Industries, Inc. Catheter tray, packaging system, instruction insert, and associated methods
US8602959B1 (en) 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
JP2009183441A (ja) 2008-02-06 2009-08-20 Ken Kondo 静脈留置針組立体
JP2011513229A (ja) * 2008-02-21 2011-04-28 イスタ・ファーマスーティカルズ・インコーポレイテッド 補助剤としての眼科用ｎｓａｉｄ
US20100152646A1 (en) 2008-02-29 2010-06-17 Reshma Girijavallabhan Intravitreal injection device and method
SI2262506T1 (sl) * 2008-03-11 2014-07-31 Alcon Research, Ltd. Močno flokulirane suspenzije triamcinolon acetonida z nizko viskoznostjo za intravitrealno injekcijo
US20090259180A1 (en) 2008-04-11 2009-10-15 Jong Soo Choi Injection method using injector with length-adjustable needle and injection apparatus using the same
US20090287161A1 (en) 2008-05-15 2009-11-19 Allergan, Inc Metered, multiple dose/aliquot syringe
US20090312782A1 (en) 2008-06-13 2009-12-17 Maxwell Choongwon Park Method and apparatus for repairing tendons
US8821870B2 (en) 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
US9022940B2 (en) 2008-07-18 2015-05-05 Joseph H. Meier Handheld imaging devices and related methods
EP2313129B1 (en) 2008-07-21 2015-01-28 Smiths Medical ASD, Inc. Tray assembly
CA2735289A1 (en) 2008-08-30 2010-03-04 Sanofi-Aventis Deutschland Gmbh Cartridge and needle system therefor
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
WO2010054660A1 (en) 2008-11-11 2010-05-20 Herlev Hospital Double cannula system for anaesthetic needle
AU2009322146B2 (en) 2008-12-05 2015-05-28 Alcon Inc. Methods and apparatus for delivering ocular implants into the eye
US20110282298A1 (en) 2008-12-09 2011-11-17 Nadav Agian Device for injecting fluid isolated from microneedle hub with dead-space-reducing insert
US8545554B2 (en) 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
US8425473B2 (en) 2009-01-23 2013-04-23 Iscience Interventional Corporation Subretinal access device
ES2378012B1 (es) 2009-01-29 2013-02-12 Innova Salud Desarrollos Sanitarios S.L. Dispositivo para la administración de productos inyectables con caudal controlado.
CA2752018C (en) 2009-02-10 2017-07-04 Psivida Us, Inc. Ocular trocar assembly
US8057483B2 (en) 2009-02-14 2011-11-15 Ocular Transplantation Llc Subretinal implantation instrument
CN201356711Y (zh) 2009-02-23 2009-12-09 徐学农 玻璃体腔冲洗针头
CA2753724C (en) 2009-03-02 2018-01-16 Sanofi-Aventis Deutschland Gmbh Medication delivery device with foldable finger pad
AU2010220254B2 (en) 2009-03-05 2014-12-04 Sanofi-Aventis Deutschland Gmbh Needle assembly
JP5570533B2 (ja) 2009-03-05 2014-08-13 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ニードルユニット
US8617121B2 (en) 2009-03-05 2013-12-31 Sanofi-Aventis Deutschland Gmbh Drug delivery device
EP2403569B1 (en) 2009-03-05 2014-04-23 Sanofi-Aventis Deutschland GmbH Drug delivery device with retractable needle
AU2010220259A1 (en) 2009-03-06 2011-09-22 Sanofi-Aventis Deutschland Gmbh Drug delivery device with retractable needle
US8287494B2 (en) 2009-03-23 2012-10-16 Colin Ma Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
SE0900371A1 (sv) 2009-03-24 2010-09-25 Istvan Bartha Anordning för distribution av flytande läkemedel
JP4505561B1 (ja) 2009-03-30 2010-07-21 篤志 今津 圧力式穿刺注射器
WO2010119392A1 (en) 2009-04-15 2010-10-21 Koninklijke Philips Electronics N.V. Needle with integrated fibers in the cutting facets of the bevel
WO2010125551A2 (en) 2009-04-29 2010-11-04 Janisys Limited A micro-needle device and apparatus and a method for applying a micro-needle element to a site on the skin of a subject
WO2010132751A1 (en) 2009-05-15 2010-11-18 Iscience Interventional Corporation Methods and apparatus for sub-retinal catheterization
WO2010149734A1 (en) 2009-06-25 2010-12-29 Sanofi-Aventis Deutschland Gmbh Cannula assembly for co-delivery of medicaments
RU2428956C2 (ru) 2009-07-13 2011-09-20 Александр Дмитриевич Ромащенко Способ лечения атрофии зрительного нерва посредством трансплантации аутологичных стволовых клеток
US8535333B2 (en) 2009-07-29 2013-09-17 Transcend Medical, Inc. Ocular implant applier and methods of use
CA2770558A1 (en) 2009-08-12 2011-02-17 Sanofi-Aventis Deutschland Gmbh Cap for a portable medical delivery device and such a medical delivery device
US8221753B2 (en) * 2009-09-30 2012-07-17 Tracon Pharmaceuticals, Inc. Endoglin antibodies
DK2470243T3 (da) 2009-08-28 2019-12-16 Sanofi Aventis Deutschland Samlesæt til fremstilling af en fyldt sprøjte
EP2480270A4 (en) 2009-09-21 2015-07-08 Harvard Apparatus Regenerative Technology Inc METHOD AND DEVICE FOR INTRODUCING CELLS TO A TISSUE POSITION
WO2011057065A1 (en) 2009-11-06 2011-05-12 The Uab Research Foundation Apparatuses and methods for delivering substances to the inner eye
CN102695533B (zh) 2009-11-11 2015-11-25 尤尼特拉克特注射器公司 医用注射器
EP2918302B1 (en) 2009-12-22 2018-11-14 UNL Holdings LLC Retractable syringe with improved delivery efficiency and locking system
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
AU2010340024A1 (en) 2010-01-05 2012-07-26 Allergan, Inc. Syringe comprising two plungers with locking means
WO2011109388A2 (en) 2010-03-01 2011-09-09 Medical Instrument Development Laboratories, Inc. Cannula for intraocular surgery
EP2364740A1 (en) 2010-03-09 2011-09-14 Sanofi-Aventis Deutschland GmbH Arrangement for transferring a translation of a drive means to a plunger
GB201004102D0 (en) 2010-03-12 2010-04-28 Liversidge Barry P Syringe barrels and handling systems
WO2011123722A1 (en) 2010-03-31 2011-10-06 Ocuject, Llc Device and method for intraocular drug delivery
EP2552349A4 (en) 2010-03-31 2017-12-06 Ocuject, LLC Device and method for intraocular drug delivery
US9320647B2 (en) 2010-03-31 2016-04-26 Ocuject, Llc Device and method for intraocular drug delivery
US9408746B2 (en) 2010-03-31 2016-08-09 Ocuject, Llc Device and method for intraocular drug delivery
US8430862B2 (en) 2010-04-08 2013-04-30 KMG Pharma LLC Subconjunctival agent delivery apparatus, system and method
US8574217B2 (en) 2010-04-08 2013-11-05 Kmg Pharma, Llc Sub-mucosal agent delivery method for the eye
US8652118B2 (en) 2010-04-08 2014-02-18 Kmg Pharma, Llc Sub-mucosal agent delivery, apparatus, system and method
WO2011135400A1 (en) 2010-04-30 2011-11-03 Indian Institute Of Technology Bombay Nanoparticulate in-situ gels as vitreous humor substitutes for ocular diseases
US8632589B2 (en) 2010-05-04 2014-01-21 Abbott Medical Optics Inc. IOL insertion system with semi-automatic trailing haptic configuration management
BR112012028038A2 (pt) 2010-05-04 2018-05-15 Unitract Syringe Pty Ltd conjunto de agulhas e adaptador de tubo de seringa
US8932258B2 (en) 2010-05-14 2015-01-13 C. R. Bard, Inc. Catheter placement device and method
US8545430B2 (en) 2010-06-09 2013-10-01 Transcend Medical, Inc. Expandable ocular devices
WO2011155988A1 (en) 2010-06-10 2011-12-15 Colantonio Anthony J Apparatus and method for safely inserting an introducer needle into epidural space
MX2012014487A (es) 2010-07-02 2013-02-21 Alcon Res Ltd Compuestos para el tratamiento de transtornos y enfermedades del segmento posterior.
KR101180032B1 (ko) 2010-07-12 2012-09-05 인싸이토(주) 외형 조절이 가능한 중공형 마이크로니들의 제조방법
TW201216948A (en) 2010-07-19 2012-05-01 Sanofi Aventis Deutschland Medicament cartridges with non-standard dimensions
US9033911B2 (en) 2010-08-05 2015-05-19 Forsight Vision4, Inc. Injector apparatus and method for drug delivery
CA2813255A1 (en) 2010-09-30 2012-04-05 Evonik Corporation Drug delivery blade and methods for delivering a drug depot to a target site
WO2012041870A1 (en) 2010-10-01 2012-04-05 Sanofi-Aventis Deutschland Gmbh Needle assembly with release mechanism
EP2438939A1 (en) 2010-10-08 2012-04-11 Sanofi-Aventis Deutschland GmbH Arrangement for coupling a plunger to either a syringe or a stopper
CN106214321B (zh) 2010-10-15 2018-08-28 科尼尔赛德生物医学公司 用于进入眼睛的装置
US20120101475A1 (en) 2010-10-21 2012-04-26 Meridian Medical Technologies, Inc. High Efficiency Auto-Injector
JP2013540028A (ja) 2010-10-25 2013-10-31 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 注射針の刺入深さを制御するためのデバイス
EP2446866A1 (en) 2010-11-02 2012-05-02 Fovea Pharmaceuticals Apparatus for injection into an eye
WO2012059456A1 (en) 2010-11-03 2012-05-10 Sanofi-Aventis Deutschland Gmbh Needle cannula containing medicament
US9241701B2 (en) 2010-11-11 2016-01-26 Depuy Mitek, Inc. Cannula system and method for partial thickness rotator cuff repair
JP5704389B2 (ja) 2010-11-29 2015-04-22 ニプロ株式会社 医療用中空針および医療用中空針の製造方法
US10285852B2 (en) 2010-12-02 2019-05-14 Tel Hashomer Medical Research Infrastructure And Services Ltd., The Chaim Sheba Medical Center Subretinal delivery of therapeutic compositions
US8608710B2 (en) 2010-12-09 2013-12-17 Becton Dickinson & Company Pen needle assembly with different gauge needle cannulas
US9968337B2 (en) 2010-12-20 2018-05-15 Cook Medical Technologies Llc Coring tissue biopsy needle and method of use
CA2828831C (en) * 2011-03-02 2019-05-07 Aquilus Pharmaceuticals, Inc. Compounds and methods for the treatment of pain and other disorders
EP2686007B1 (en) * 2011-03-15 2019-04-24 University of Utah Research Foundation Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
USD667111S1 (en) 2011-03-17 2012-09-11 Surgical Innovations Limited Handle for surgical instrument
EP2500002A1 (en) 2011-03-17 2012-09-19 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
US20140088552A1 (en) 2011-03-25 2014-03-27 The Curators Of The University Of Missouri Intravitreal Injection Device
EP2510911A1 (en) 2011-04-13 2012-10-17 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
EP2510902A1 (en) 2011-04-15 2012-10-17 Sanofi-Aventis Deutschland GmbH Intraocular injection device
EP2514684A1 (en) 2011-04-20 2012-10-24 Becton Dickinson France Packaging for medical containers
EP2514461A1 (en) 2011-04-20 2012-10-24 Sanofi-Aventis Deutschland GmbH Needle assembly for a medical device
EP2522318A1 (en) 2011-05-12 2012-11-14 Sanofi-Aventis Deutschland GmbH Guide device for intraocular injection
WO2012162459A1 (en) 2011-05-26 2012-11-29 Pepose Jay Device and method for administering eye medications
EP2540261A1 (en) 2011-06-30 2013-01-02 Sanofi-Aventis Deutschland GmbH Intraocular medicament delivery device
WO2013022772A1 (en) 2011-08-05 2013-02-14 Unitract Syringe Pty Ltd Cannula with controlled depth of insertion
EP2755705B1 (en) 2011-09-13 2015-11-25 Sanofi-Aventis Deutschland GmbH Injection device
EP2574355A1 (en) 2011-09-27 2013-04-03 Sanofi-Aventis Deutschland GmbH Package for a medicament delivery device
EP2578191A1 (en) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
EP2578260A1 (en) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
EP2578190A1 (en) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Intraocular injection device
EP2578189A1 (en) 2011-10-07 2013-04-10 Sanofi-Aventis Deutschland GmbH Apparatus for intraocular injection
EP2586407A1 (en) 2011-10-31 2013-05-01 Sanofi-Aventis Deutschland GmbH Aid device for intraocular injection
EP2596826A1 (en) 2011-11-24 2013-05-29 Sanofi-Aventis Deutschland GmbH Safety syringe
EP2601990A1 (en) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Syringe carrier
US9345839B2 (en) 2011-12-08 2016-05-24 Unitract Syringe Pty Ltd Accurate dose control mechanisms and drug delivery syringes
EP2601992A1 (en) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Syringe carrier
EP2601988A1 (en) 2011-12-08 2013-06-12 Sanofi-Aventis Deutschland GmbH Syringe carrier
US20150013827A1 (en) 2011-12-15 2015-01-15 Sanofi Sa Reservoir or medicated module for a drug delivery system and method of and assembly for filling the same
ES2533576T3 (es) 2011-12-30 2015-04-13 Q-Med Ab Cánula sin hematomas
AU344164S (en) 2012-02-02 2012-09-04 Terumo Corp Safety device for indwelling needle
EP2626096A1 (en) 2012-02-10 2013-08-14 Sanofi-Aventis Deutschland GmbH Medicament delivery device with needle assembly removal mechanism
CN110251766A (zh) 2012-02-20 2019-09-20 泰尔茂株式会社 医疗用具包装体
US20150037422A1 (en) * 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
CA2865273C (en) 2012-02-22 2018-06-05 Ira H. Schachar Device and method for treatment of retinal detachment and other maladies of the eye
CA2864707A1 (en) 2012-02-23 2013-08-29 Unitract Syringe Pty Ltd Devices for targeted delivery of therapeutic implants
USD672506S1 (en) 2012-02-28 2012-12-11 Idea Village Products, Inc. Exfoliating device
JP2015508690A (ja) 2012-02-29 2015-03-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 容器から薬剤を１回だけ引き出すための引出しデバイス
HK1202463A1 (en) 2012-03-12 2015-10-02 Unitract Syringe Pty Ltd Fill-finish cartridges for sterile fluid pathway assemblies and drug delivery devices incorporating fill-finish cartridges
EP2641629A1 (en) 2012-03-22 2013-09-25 Sanofi-Aventis Deutschland GmbH Medical injection device with injection site pain reduction device
US9421129B2 (en) 2012-04-02 2016-08-23 Ocuject, Llc Intraocular delivery devices and methods therefor
US9833523B2 (en) 2012-04-24 2017-12-05 The Ohio State University Pharmacokinetic determination of intravitreal agents
US9889248B2 (en) 2012-05-21 2018-02-13 Baxalta GmbH Syringe storage tray
HK1204564A1 (en) 2012-06-25 2015-11-27 Bayer Healthcare Llc Topical ophthalmological pharmaceutical composition containing axitinib
US9956341B2 (en) 2012-07-03 2018-05-01 Milestone Scientific, Inc. Drug infusion with pressure sensing and non-continuous flow for identification of and injection into fluid-filled anatomic spaces
US8727117B2 (en) 2012-07-16 2014-05-20 Becton, Dickinson And Company Package for syringe
US10201655B2 (en) 2012-08-13 2019-02-12 The Brigham And Women's Hospital, Inc. Methods and devices for inserting a needle
US20150209180A1 (en) 2012-08-27 2015-07-30 Clearside Biomedical, Inc. Apparatus and Methods for Drug Delivery Using Microneedles
USD715125S1 (en) 2012-10-08 2014-10-14 The Ames Companies, Inc. Grip
EP3721872B1 (en) 2012-11-08 2025-01-22 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
US9022968B2 (en) 2013-01-08 2015-05-05 University Of South Florida Auto-regulation system for intraocular pressure
US9968603B2 (en) 2013-03-14 2018-05-15 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
USD740098S1 (en) 2013-03-19 2015-10-06 Tong Yah Electronic Technology Co., Ltd. Vehicular handle
US9987163B2 (en) 2013-04-16 2018-06-05 Novartis Ag Device for dispensing intraocular substances
EP2991706B1 (en) 2013-05-03 2021-06-23 Clearside Biomedical, Inc. Apparatus and methods for ocular injection
WO2014197317A1 (en) 2013-06-03 2014-12-11 Clearside Biomedical, Inc. Apparatus and methods for drug delivery using multiple reservoirs
JP6594869B2 (ja) 2013-08-02 2019-10-23 テル ハショメール メディカル リサーチ インフラストラクチュアー アンド サービス エルティーディー． 目に組成物を輸送するためのデバイス
HK1226134A1 (zh) 2013-08-07 2017-09-22 Unitract Syringe Pty Ltd 用於注射器的鲁尔连接适配器
US9931480B2 (en) 2013-08-07 2018-04-03 Unitract Syringe Pty Ltd Luer connection adapters for retractable needle syringes
USD718602S1 (en) 2013-09-09 2014-12-02 Midwest Tool And Cutlery Company Hand grip for hand tools
USD713958S1 (en) 2013-12-05 2014-09-23 Becton, Dickinson And Company Pen needle outer cover
US20160310417A1 (en) 2013-12-20 2016-10-27 Emory University Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents
USD726908S1 (en) 2014-02-06 2015-04-14 St. Jude Medical, Cardiology Division, Inc. Catheter handle
CA2952822A1 (en) 2014-06-17 2015-12-23 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorders
MX2016017028A (es) 2014-06-20 2017-08-07 Clearside Biomedical Inc Canula de diametro variable y metodos para el control de la profundidad de insercion para administracion de medicamentos.
KR20170060074A (ko) 2014-09-19 2017-05-31 옥슬러 리미티드 안과용 전달 장치
JP6819908B2 (ja) 2014-09-19 2021-01-27 オクラー リミテッド 眼科用医薬組成物
USD750223S1 (en) 2014-10-14 2016-02-23 Clearside Biomedical, Inc. Medical injector for ocular injection
US11369591B2 (en) 2015-05-12 2022-06-28 Incept, Llc Drug delivery from hydrogels
WO2017120600A1 (en) 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Compositions and methods of treating wet age-related macular degeneration
CA3010862A1 (en) 2016-01-08 2017-07-13 Clearside Biomedical, Inc. Methods and devices for treating posterior ocular disorderswith aflibercept and other biologics
EP3413851B1 (en) 2016-02-10 2023-09-27 Clearside Biomedical, Inc. Packaging
WO2017190142A1 (en) 2016-04-29 2017-11-02 Clearside Biomedical, Inc. Formulations and methods for reduction of intraocular pressure
EP3452165A1 (en) 2016-05-02 2019-03-13 Clearside Biomedical, Inc. Systems and methods for ocular drug delivery
CN110177527B (zh) 2016-08-12 2022-02-01 科尼尔赛德生物医学公司 用于调节药剂递送用针的插入深度的装置和方法
WO2018204515A1 (en) 2017-05-02 2018-11-08 Georgia Tech Research Corporation Targeted drug delivery methods using a microneedle
KR20200060456A (ko) 2017-09-27 2020-05-29 리젠엑스바이오 인크. 완전-인간 번역후 변형된 항-VEGF Fab를 이용한 안구 질환의 치료
US20190269702A1 (en) 2018-03-05 2019-09-05 Clearside Biomedical, Inc. Compositions and methods for treating noninfectious uveitis
KR20220019667A (ko) 2019-04-16 2022-02-17 클리어사이드 바이오메디컬, 인코포레이드 주사 가능한 트리암시놀론 제형
CN119745879A (zh) 2020-02-19 2025-04-04 科尼尔赛德生物医学公司 包含阿西替尼的组合物和治疗眼部疾病的方法
US20230201371A1 (en) 2020-03-19 2023-06-29 Clearside Biomedical, Inc. Compositions and methods for treating ocular disorders

Also Published As

Publication number Publication date
KR20210133321A (ko) 2021-11-05
KR102467714B1 (ko) 2022-11-16
ES2813869T3 (es) 2021-03-25
IL238432B (en) 2020-05-31
MX2020005126A (es) 2022-01-27
JP2018090632A (ja) 2018-06-14
US12350261B2 (en) 2025-07-08
US20190240208A1 (en) 2019-08-08
US9572800B2 (en) 2017-02-21
AU2017272182A1 (en) 2017-12-21
EP2916827A4 (en) 2016-12-07
CA2890471A1 (en) 2014-05-15
US20160206628A1 (en) 2016-07-21
MX373894B (es) 2020-07-09
WO2014074823A1 (en) 2014-05-15
US9636332B2 (en) 2017-05-02
JP2015535293A (ja) 2015-12-10
CN104884049A (zh) 2015-09-02
US20210260047A1 (en) 2021-08-26
US20180325884A1 (en) 2018-11-15
AU2013342275A1 (en) 2015-05-14
MX2015005839A (es) 2015-12-17
CA3240136A1 (en) 2014-05-15
US20170333416A1 (en) 2017-11-23
JP2022119912A (ja) 2022-08-17
IL238432A0 (en) 2015-06-30
CN110893188A (zh) 2020-03-20
US20200383965A1 (en) 2020-12-10
US20180092897A1 (en) 2018-04-05
US20180028516A1 (en) 2018-02-01
AU2013342275B2 (en) 2017-11-09
KR20150083117A (ko) 2015-07-16
EA034963B1 (ru) 2020-04-13
EP4566672A2 (en) 2025-06-11
US9931330B2 (en) 2018-04-03
KR20210032571A (ko) 2021-03-24
CA2890471C (en) 2021-07-27
PH12015500986A1 (en) 2015-08-03
EP2916827A1 (en) 2015-09-16
MX389676B (es) 2025-03-20
EA201590902A1 (ru) 2016-02-29
BR112015010566A2 (pt) 2017-07-11
JP2025010589A (ja) 2025-01-22
US20150258120A1 (en) 2015-09-17
SG11201503637SA (en) 2015-06-29
EP4566672A3 (en) 2025-08-13
JP2020033381A (ja) 2020-03-05
JP6487848B2 (ja) 2019-03-20
EP3721872A1 (en) 2020-10-14
CA3121763A1 (en) 2014-05-15
HK1213192A1 (en) 2016-06-30
US20160213662A1 (en) 2016-07-28
JP7576061B2 (ja) 2024-10-30
EP2916827B1 (en) 2020-06-10
JP7082599B2 (ja) 2022-06-08
EP3721872B1 (en) 2025-01-22

Similar Documents

Publication Publication Date Title
US12350261B2 (en) Methods and devices for the treatment of ocular diseases in human subjects
US20220280341A1 (en) Apparatus and methods for drug delivery using microneedles
US20160310417A1 (en) Formulations and Methods For Targeted Ocular Delivery of Therapeutic Agents
CA3121763C (en) Methods and devices for the treatment of ocular diseases in human subjects
HK40041836B (en) Methods for the treatment of ocular disease in human subjects
HK40041836A (en) Methods for the treatment of ocular disease in human subjects
HK1213192B (en) Methods for the treatment of ocular disease in human subjects